Medical Properties Trust (MPW) Stock Forecast & Price Target

$5.95

+0.05 (+0.85%)

(As of 09/27/2024 ET)

Medical Properties Trust - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce

Based on 11 Analyst Ratings

Sell
2

Hold
8

Buy
1

Based on 11 Wall Street analysts who have issued ratings for Medical Properties Trust in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 11 analysts, 2 have given a sell rating, 8 have given a hold rating, and 1 has given a buy rating for MPW.

Consensus Price Target

$5.22
-12.23% Downside

According to the 11 analysts' twelve-month price targets for Medical Properties Trust, the average price target is $5.22. The highest price target for MPW is $7.00, while the lowest price target for MPW is $4.00. The average price target represents a forecasted downside of -12.23% from the current price of $5.95.

Get the Latest News and Ratings for MPW and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Medical Properties Trust and its competitors.

MPW Analyst Ratings Over Time

Type	Current Forecast 9/30/23 to 9/29/24	1 Month Ago 8/31/23 to 8/30/24	3 Months Ago 7/2/23 to 7/1/24	1 Year Ago 9/30/22 to 9/30/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	0 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	7 Hold rating(s)	4 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	4 Sell rating(s)	3 Sell rating(s)
Consensus Price Target	$5.22	$4.86	$5.80	$10.27
Forecasted Upside	-12.23% Downside	8.14% Upside	41.53% Upside	88.49% Upside
Consensus Rating	Reduce	Reduce	Reduce	Hold

Massive NVIDIA Sell-Off: Are We Headed for a Market Collapse? (Ad)

You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...

Click here for his urgent warning - and 4 steps you need to take today to protect your retirement to

MPW Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MPW Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Medical Properties Trust Stock vs. The Competition

Type	Medical Properties Trust	Finance Companies	S&P 500
Consensus Rating Score	1.91	2.46	2.50
Consensus Rating	Reduce	Hold	Hold
Predicted Upside	-12.23% Downside	12.81% Upside	6.15% Upside
News Sentiment Rating	Positive News See Recent MPW News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/23/2024	Wolfe Research 3 of 5 stars	A. Rosivach Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
9/13/2024	Truist Financial 2 of 5 stars		Boost Target	Hold ➝ Hold	$5.00 ➝ $6.00	+6.86%
9/13/2024	Colliers Securities 1 of 5 stars	B. Oxford Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$6.50	+15.76%
7/2/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Crossett Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$6.00 ➝ $4.00	-2.32%
5/14/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Sector Perform	$5.00	-10.23%
4/17/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Hold	$2.00 ➝ $5.00	+4.17%
Get the Latest News and Ratings for MPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medical Properties Trust and its competitors with MarketBeat's FREE daily newsletter.
1/5/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Sector Weight
1/3/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$9.00 ➝ $7.00	+38.34%
11/29/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$8.00 ➝ $5.00	+3.31%
11/10/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$12.00 ➝ $4.50	-3.12%
10/16/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Equal Weight ➝ Underweight	$7.00 ➝ $4.00	-19.35%
8/22/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$12.00 ➝ $10.00	+42.65%
8/11/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Strong-Buy ➝ Underperform
8/11/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform	$9.00 ➝ $8.00	-1.60%
3/7/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral	$11.00	+9.34%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 05:25 AM ET.

MPW Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Medical Properties Trust is $5.22, with a high forecast of $7.00 and a low forecast of $4.00.
: 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last year. There are currently 2 sell ratings, 8 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" MPW shares.
: According to analysts, Medical Properties Trust's stock has a predicted downside of -12.23% based on their 12-month stock forecasts.
: Over the previous 90 days, Medical Properties Trust's stock had 2 upgrades and 1 downgrade by analysts.
: Medical Properties Trust has been rated by research analysts at BNP Paribas, Colliers Securities, Truist Financial, and Wolfe Research in the past 90 days.
: Analysts like Medical Properties Trust less than other "finance" companies. The consensus rating for Medical Properties Trust is Reduce while the average consensus rating for "finance" companies is Hold. Learn more on how MPW compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Massive NVIDIA Sell-Off: Are We Headed for a Market Collapse? (Ad)

You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...

Click here for his urgent warning - and 4 steps you need to take today to protect your retirement to

This page (NYSE:MPW) was last updated on 9/29/2024 by MarketBeat.com Staff

From Our Partners